Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | MMP12 | P39900 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.50 |
| ▸ | RARB | P10826 | 3/20 | 0.48 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6937097 | 1.00 | MMP2 (0.59) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL7337990 | 0.99 | MMP2 (0.56) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL181321 | 0.86 | MMP2 (0.52) | MMP2MMP12FFAR1FFAR4 | |
| SCHEMBL30143434 | 0.86 | MMP2 (0.72) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL4271492 | 0.86 | MMP2 (0.72) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL6934491 | 0.86 | MMP2 (0.72) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL6934714 | 0.85 | MMP2 (0.51) | MMP2MMP12FFAR1FFAR4 | |
| SCHEMBL7330109 | 0.84 | MMP2 (0.50) | MMP2MMP12FFAR1FFAR4 | |
| SCHEMBL6937361 | 0.84 | MMP2 (0.69) | MMP2MMP12FFAR1FFAR4TP53 | |
| SCHEMBL6936308 | 0.82 | MMP2 (0.67) | MMP2MMP12FFAR1FFAR4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010098372-A1 | FIELD EFFECT TRANSISTOR | 国立大学法人広島大学 (JP) | 2010-09-02 | — | — | WO | disclosed |